Koninklijke Philips N.V.
Koninklijke Philips N.V. (RYLPF) Stock Competitors & Peer Comparison
See (RYLPF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RYLPF | $27.08 | -1.85% | 25.7B | 142.53 | $0.19 | +3.51% |
| SMMNY | $28.09 | +1.78% | 125.8B | 25.04 | $1.12 | +1.86% |
| SEMHF | $56.46 | +0.82% | 63.7B | 25.26 | $2.25 | +1.74% |
| SONVY | $58.05 | +1.89% | 17.3B | 25.95 | $2.24 | +1.85% |
| SONVF | $290.28 | +1.82% | 17.3B | 25.92 | $11.20 | +1.87% |
| SNNUF | $17.30 | +0.00% | 15.1B | 30.89 | $0.56 | +2.17% |
| CHEOY | $97.97 | +0.91% | 12.9B | 51.28 | $1.92 | +1.42% |
| CHEOF | $183.04 | +0.00% | 12B | 47.67 | $3.84 | +1.51% |
| WILYY | $18.99 | +0.00% | 8.5B | 19.58 | $0.97 | N/A |
| WILLF | $40.14 | +1.01% | 8.2B | 20.69 | $1.94 | N/A |
Stock Comparison
RYLPF vs SMMNY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, SMMNY has a market cap of 125.8B. Regarding current trading prices, RYLPF is priced at $27.08, while SMMNY trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas SMMNY's P/E ratio is 25.04. In terms of profitability, RYLPF's ROE is +0.01%, compared to SMMNY's ROE of +0.12%. Regarding short-term risk, RYLPF is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check SMMNY's competition here
RYLPF vs SEMHF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, SEMHF has a market cap of 63.7B. Regarding current trading prices, RYLPF is priced at $27.08, while SEMHF trades at $56.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas SEMHF's P/E ratio is 25.26. In terms of profitability, RYLPF's ROE is +0.01%, compared to SEMHF's ROE of +0.12%. Regarding short-term risk, RYLPF is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check SEMHF's competition here
RYLPF vs SONVY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, SONVY has a market cap of 17.3B. Regarding current trading prices, RYLPF is priced at $27.08, while SONVY trades at $58.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas SONVY's P/E ratio is 25.95. In terms of profitability, RYLPF's ROE is +0.01%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, RYLPF is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check SONVY's competition here
RYLPF vs SONVF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, SONVF has a market cap of 17.3B. Regarding current trading prices, RYLPF is priced at $27.08, while SONVF trades at $290.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas SONVF's P/E ratio is 25.92. In terms of profitability, RYLPF's ROE is +0.01%, compared to SONVF's ROE of +0.22%. Regarding short-term risk, RYLPF is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check SONVF's competition here
RYLPF vs SNNUF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, SNNUF has a market cap of 15.1B. Regarding current trading prices, RYLPF is priced at $27.08, while SNNUF trades at $17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas SNNUF's P/E ratio is 30.89. In terms of profitability, RYLPF's ROE is +0.01%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, RYLPF is less volatile compared to SNNUF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check SNNUF's competition here
RYLPF vs CHEOY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, CHEOY has a market cap of 12.9B. Regarding current trading prices, RYLPF is priced at $27.08, while CHEOY trades at $97.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas CHEOY's P/E ratio is 51.28. In terms of profitability, RYLPF's ROE is +0.01%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, RYLPF is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check CHEOY's competition here
RYLPF vs CHEOF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, CHEOF has a market cap of 12B. Regarding current trading prices, RYLPF is priced at $27.08, while CHEOF trades at $183.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas CHEOF's P/E ratio is 47.67. In terms of profitability, RYLPF's ROE is +0.01%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, RYLPF is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check CHEOF's competition here
RYLPF vs WILYY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, WILYY has a market cap of 8.5B. Regarding current trading prices, RYLPF is priced at $27.08, while WILYY trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas WILYY's P/E ratio is 19.58. In terms of profitability, RYLPF's ROE is +0.01%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, RYLPF is less volatile compared to WILYY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check WILYY's competition here
RYLPF vs WILLF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, WILLF has a market cap of 8.2B. Regarding current trading prices, RYLPF is priced at $27.08, while WILLF trades at $40.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas WILLF's P/E ratio is 20.69. In terms of profitability, RYLPF's ROE is +0.01%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, RYLPF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check WILLF's competition here
RYLPF vs GNGBY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, GNGBY has a market cap of 6B. Regarding current trading prices, RYLPF is priced at $27.08, while GNGBY trades at $21.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas GNGBY's P/E ratio is 38.39. In terms of profitability, RYLPF's ROE is +0.01%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, RYLPF is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check GNGBY's competition here
RYLPF vs GNGBF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, GNGBF has a market cap of 5.7B. Regarding current trading prices, RYLPF is priced at $27.08, while GNGBF trades at $21.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas GNGBF's P/E ratio is 36.84. In terms of profitability, RYLPF's ROE is +0.01%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, RYLPF is less volatile compared to GNGBF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check GNGBF's competition here
RYLPF vs AMBBY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, AMBBY has a market cap of 4.2B. Regarding current trading prices, RYLPF is priced at $27.08, while AMBBY trades at $15.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas AMBBY's P/E ratio is 72.05. In terms of profitability, RYLPF's ROE is +0.01%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, RYLPF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check AMBBY's competition here
RYLPF vs AMBFF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, AMBFF has a market cap of 4.1B. Regarding current trading prices, RYLPF is priced at $27.08, while AMBFF trades at $15.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas AMBFF's P/E ratio is 72.90. In terms of profitability, RYLPF's ROE is +0.01%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, RYLPF is more volatile compared to AMBFF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check AMBFF's competition here
RYLPF vs NHNKY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, NHNKY has a market cap of 3.7B. Regarding current trading prices, RYLPF is priced at $27.08, while NHNKY trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas NHNKY's P/E ratio is 19.30. In terms of profitability, RYLPF's ROE is +0.01%, compared to NHNKY's ROE of +0.08%. Regarding short-term risk, RYLPF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check NHNKY's competition here
RYLPF vs MCRPF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, MCRPF has a market cap of 3.3B. Regarding current trading prices, RYLPF is priced at $27.08, while MCRPF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas MCRPF's P/E ratio is -15.00. In terms of profitability, RYLPF's ROE is +0.01%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, RYLPF is less volatile compared to MCRPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check MCRPF's competition here
RYLPF vs GNNDY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, GNNDY has a market cap of 2.7B. Regarding current trading prices, RYLPF is priced at $27.08, while GNNDY trades at $56.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas GNNDY's P/E ratio is 21.64. In terms of profitability, RYLPF's ROE is +0.01%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, RYLPF is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check GNNDY's competition here
RYLPF vs GGNDF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, GGNDF has a market cap of 2.6B. Regarding current trading prices, RYLPF is priced at $27.08, while GGNDF trades at $17.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas GGNDF's P/E ratio is 20.56. In terms of profitability, RYLPF's ROE is +0.01%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, RYLPF is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check GGNDF's competition here
RYLPF vs NHNKF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, RYLPF is priced at $27.08, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, RYLPF's ROE is +0.01%, compared to NHNKF's ROE of +0.08%. Regarding short-term risk, RYLPF is less volatile compared to NHNKF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check NHNKF's competition here
RYLPF vs OSSFF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, OSSFF has a market cap of 2B. Regarding current trading prices, RYLPF is priced at $27.08, while OSSFF trades at $4.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas OSSFF's P/E ratio is 28.24. In terms of profitability, RYLPF's ROE is +0.01%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, RYLPF is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check OSSFF's competition here
RYLPF vs STSEY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, RYLPF is priced at $27.08, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas STSEY's P/E ratio is 39.41. In terms of profitability, RYLPF's ROE is +0.01%, compared to STSEY's ROE of +0.07%. Regarding short-term risk, RYLPF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check STSEY's competition here
RYLPF vs VTRLY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, VTRLY has a market cap of 2B. Regarding current trading prices, RYLPF is priced at $27.08, while VTRLY trades at $14.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas VTRLY's P/E ratio is 42.80. In terms of profitability, RYLPF's ROE is +0.01%, compared to VTRLY's ROE of +0.03%. Regarding short-term risk, RYLPF is less volatile compared to VTRLY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check VTRLY's competition here
RYLPF vs DWRKF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, RYLPF is priced at $27.08, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, RYLPF's ROE is +0.01%, compared to DWRKF's ROE of N/A. Regarding short-term risk, RYLPF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check DWRKF's competition here
RYLPF vs OSSUY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, RYLPF is priced at $27.08, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, RYLPF's ROE is +0.01%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, RYLPF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check OSSUY's competition here
RYLPF vs MEDGF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, RYLPF is priced at $27.08, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, RYLPF's ROE is +0.01%, compared to MEDGF's ROE of +0.21%. Regarding short-term risk, RYLPF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check MEDGF's competition here
RYLPF vs DRWKF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, DRWKF has a market cap of 1.4B. Regarding current trading prices, RYLPF is priced at $27.08, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas DRWKF's P/E ratio is 9.40. In terms of profitability, RYLPF's ROE is +0.01%, compared to DRWKF's ROE of +0.07%. Regarding short-term risk, RYLPF is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check DRWKF's competition here
RYLPF vs DGWPF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, DGWPF has a market cap of 1.1B. Regarding current trading prices, RYLPF is priced at $27.08, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas DGWPF's P/E ratio is 9.24. In terms of profitability, RYLPF's ROE is +0.01%, compared to DGWPF's ROE of +0.07%. Regarding short-term risk, RYLPF is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check DGWPF's competition here
RYLPF vs LFTSF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, RYLPF is priced at $27.08, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, RYLPF's ROE is +0.01%, compared to LFTSF's ROE of +0.06%. Regarding short-term risk, RYLPF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check LFTSF's competition here
RYLPF vs ELEAF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, ELEAF has a market cap of 1B. Regarding current trading prices, RYLPF is priced at $27.08, while ELEAF trades at $12.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas ELEAF's P/E ratio is 14.07. In terms of profitability, RYLPF's ROE is +0.01%, compared to ELEAF's ROE of +0.15%. Regarding short-term risk, RYLPF is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check ELEAF's competition here
RYLPF vs MDRSF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, MDRSF has a market cap of 828.1M. Regarding current trading prices, RYLPF is priced at $27.08, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, RYLPF's ROE is +0.01%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, RYLPF is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check MDRSF's competition here
RYLPF vs XVIPF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, XVIPF has a market cap of 646.9M. Regarding current trading prices, RYLPF is priced at $27.08, while XVIPF trades at $20.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas XVIPF's P/E ratio is 55.50. In terms of profitability, RYLPF's ROE is +0.01%, compared to XVIPF's ROE of +0.05%. Regarding short-term risk, RYLPF is less volatile compared to XVIPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check XVIPF's competition here
RYLPF vs AVMR Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, RYLPF is priced at $27.08, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas AVMR's P/E ratio is -18.34. In terms of profitability, RYLPF's ROE is +0.01%, compared to AVMR's ROE of -0.92%. Regarding short-term risk, RYLPF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check AVMR's competition here
RYLPF vs CALZF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, CALZF has a market cap of 475.6M. Regarding current trading prices, RYLPF is priced at $27.08, while CALZF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas CALZF's P/E ratio is 68.84. In terms of profitability, RYLPF's ROE is +0.01%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, RYLPF is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check CALZF's competition here
RYLPF vs CLVSF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, CLVSF has a market cap of 459.8M. Regarding current trading prices, RYLPF is priced at $27.08, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, RYLPF's ROE is +0.01%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, RYLPF is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check CLVSF's competition here
RYLPF vs IOBCF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, IOBCF has a market cap of 388.2M. Regarding current trading prices, RYLPF is priced at $27.08, while IOBCF trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas IOBCF's P/E ratio is 35.81. In terms of profitability, RYLPF's ROE is +0.01%, compared to IOBCF's ROE of +0.09%. Regarding short-term risk, RYLPF is less volatile compared to IOBCF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check IOBCF's competition here
RYLPF vs CSSPF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, CSSPF has a market cap of 384.4M. Regarding current trading prices, RYLPF is priced at $27.08, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas CSSPF's P/E ratio is 92.00. In terms of profitability, RYLPF's ROE is +0.01%, compared to CSSPF's ROE of +0.05%. Regarding short-term risk, RYLPF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check CSSPF's competition here
RYLPF vs HYBT Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, RYLPF is priced at $27.08, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas HYBT's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.01%, compared to HYBT's ROE of +0.00%. Regarding short-term risk, RYLPF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check HYBT's competition here
RYLPF vs EAPIF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, EAPIF has a market cap of 293.9M. Regarding current trading prices, RYLPF is priced at $27.08, while EAPIF trades at $3.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas EAPIF's P/E ratio is -2.02. In terms of profitability, RYLPF's ROE is +0.01%, compared to EAPIF's ROE of -0.14%. Regarding short-term risk, RYLPF is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check EAPIF's competition here
RYLPF vs HTLZF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, RYLPF is priced at $27.08, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, RYLPF's ROE is +0.01%, compared to HTLZF's ROE of -0.04%. Regarding short-term risk, RYLPF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check HTLZF's competition here
RYLPF vs CYBQY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, CYBQY has a market cap of 238.1M. Regarding current trading prices, RYLPF is priced at $27.08, while CYBQY trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas CYBQY's P/E ratio is -66.75. In terms of profitability, RYLPF's ROE is +0.01%, compared to CYBQY's ROE of -0.01%. Regarding short-term risk, RYLPF is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check CYBQY's competition here
RYLPF vs BCCOY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, BCCOY has a market cap of 225.8M. Regarding current trading prices, RYLPF is priced at $27.08, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas BCCOY's P/E ratio is -5.33. In terms of profitability, RYLPF's ROE is +0.01%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, RYLPF is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check BCCOY's competition here
RYLPF vs BRSYF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, BRSYF has a market cap of 207.5M. Regarding current trading prices, RYLPF is priced at $27.08, while BRSYF trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas BRSYF's P/E ratio is 39.21. In terms of profitability, RYLPF's ROE is +0.01%, compared to BRSYF's ROE of +0.09%. Regarding short-term risk, RYLPF is more volatile compared to BRSYF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check BRSYF's competition here
RYLPF vs IMPZY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, IMPZY has a market cap of 198.4M. Regarding current trading prices, RYLPF is priced at $27.08, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, RYLPF's ROE is +0.01%, compared to IMPZY's ROE of -15.79%. Regarding short-term risk, RYLPF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check IMPZY's competition here
RYLPF vs CLLKF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, CLLKF has a market cap of 196.2M. Regarding current trading prices, RYLPF is priced at $27.08, while CLLKF trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas CLLKF's P/E ratio is -4.73. In terms of profitability, RYLPF's ROE is +0.01%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, RYLPF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check CLLKF's competition here
RYLPF vs PXMBF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, PXMBF has a market cap of 182.1M. Regarding current trading prices, RYLPF is priced at $27.08, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, RYLPF's ROE is +0.01%, compared to PXMBF's ROE of +0.12%. Regarding short-term risk, RYLPF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check PXMBF's competition here
RYLPF vs DTXMF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, RYLPF is priced at $27.08, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, RYLPF's ROE is +0.01%, compared to DTXMF's ROE of -0.45%. Regarding short-term risk, RYLPF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check DTXMF's competition here
RYLPF vs EKDHF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, EKDHF has a market cap of 175.1M. Regarding current trading prices, RYLPF is priced at $27.08, while EKDHF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas EKDHF's P/E ratio is 19.50. In terms of profitability, RYLPF's ROE is +0.01%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, RYLPF is more volatile compared to EKDHF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check EKDHF's competition here
RYLPF vs CYBQF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, CYBQF has a market cap of 172.8M. Regarding current trading prices, RYLPF is priced at $27.08, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas CYBQF's P/E ratio is -64.75. In terms of profitability, RYLPF's ROE is +0.01%, compared to CYBQF's ROE of -0.01%. Regarding short-term risk, RYLPF is less volatile compared to CYBQF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check CYBQF's competition here
RYLPF vs DMTRF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, DMTRF has a market cap of 168.4M. Regarding current trading prices, RYLPF is priced at $27.08, while DMTRF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas DMTRF's P/E ratio is -8.82. In terms of profitability, RYLPF's ROE is +0.01%, compared to DMTRF's ROE of -0.65%. Regarding short-term risk, RYLPF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check DMTRF's competition here
RYLPF vs FDMDF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, FDMDF has a market cap of 136.3M. Regarding current trading prices, RYLPF is priced at $27.08, while FDMDF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas FDMDF's P/E ratio is -4.18. In terms of profitability, RYLPF's ROE is +0.01%, compared to FDMDF's ROE of -0.51%. Regarding short-term risk, RYLPF is less volatile compared to FDMDF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check FDMDF's competition here
RYLPF vs AVHHL Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, AVHHL has a market cap of 128.4M. Regarding current trading prices, RYLPF is priced at $27.08, while AVHHL trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas AVHHL's P/E ratio is -2.08. In terms of profitability, RYLPF's ROE is +0.01%, compared to AVHHL's ROE of +279.91%. Regarding short-term risk, RYLPF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check AVHHL's competition here
RYLPF vs AMEUF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, RYLPF is priced at $27.08, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, RYLPF's ROE is +0.01%, compared to AMEUF's ROE of -2.19%. Regarding short-term risk, RYLPF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check AMEUF's competition here
RYLPF vs SNZZF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, SNZZF has a market cap of 110.9M. Regarding current trading prices, RYLPF is priced at $27.08, while SNZZF trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas SNZZF's P/E ratio is -7.05. In terms of profitability, RYLPF's ROE is +0.01%, compared to SNZZF's ROE of -0.39%. Regarding short-term risk, RYLPF is less volatile compared to SNZZF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check SNZZF's competition here
RYLPF vs VMTHF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, VMTHF has a market cap of 110M. Regarding current trading prices, RYLPF is priced at $27.08, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, RYLPF's ROE is +0.01%, compared to VMTHF's ROE of -0.29%. Regarding short-term risk, RYLPF is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check VMTHF's competition here
RYLPF vs JMDMF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, JMDMF has a market cap of 104.4M. Regarding current trading prices, RYLPF is priced at $27.08, while JMDMF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas JMDMF's P/E ratio is -27.83. In terms of profitability, RYLPF's ROE is +0.01%, compared to JMDMF's ROE of N/A. Regarding short-term risk, RYLPF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check JMDMF's competition here
RYLPF vs SOMNF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, SOMNF has a market cap of 96M. Regarding current trading prices, RYLPF is priced at $27.08, while SOMNF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas SOMNF's P/E ratio is -14.67. In terms of profitability, RYLPF's ROE is +0.01%, compared to SOMNF's ROE of -0.20%. Regarding short-term risk, RYLPF is less volatile compared to SOMNF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check SOMNF's competition here
RYLPF vs RSHUF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, RYLPF is priced at $27.08, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, RYLPF's ROE is +0.01%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, RYLPF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check RSHUF's competition here
RYLPF vs CKMTF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, RYLPF is priced at $27.08, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, RYLPF's ROE is +0.01%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, RYLPF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check CKMTF's competition here
RYLPF vs IPDQF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, IPDQF has a market cap of 50.7M. Regarding current trading prices, RYLPF is priced at $27.08, while IPDQF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas IPDQF's P/E ratio is -2.50. In terms of profitability, RYLPF's ROE is +0.01%, compared to IPDQF's ROE of -0.39%. Regarding short-term risk, RYLPF is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check IPDQF's competition here
RYLPF vs BLOZF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, BLOZF has a market cap of 49M. Regarding current trading prices, RYLPF is priced at $27.08, while BLOZF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas BLOZF's P/E ratio is -21.28. In terms of profitability, RYLPF's ROE is +0.01%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, RYLPF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check BLOZF's competition here
RYLPF vs RDGL Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, RDGL has a market cap of 48.1M. Regarding current trading prices, RYLPF is priced at $27.08, while RDGL trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas RDGL's P/E ratio is -10.60. In terms of profitability, RYLPF's ROE is +0.01%, compared to RDGL's ROE of -1.45%. Regarding short-term risk, RYLPF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check RDGL's competition here
RYLPF vs BRNHF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, BRNHF has a market cap of 42.3M. Regarding current trading prices, RYLPF is priced at $27.08, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, RYLPF's ROE is +0.01%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, RYLPF is more volatile compared to BRNHF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check BRNHF's competition here
RYLPF vs TLTFF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, TLTFF has a market cap of 40.9M. Regarding current trading prices, RYLPF is priced at $27.08, while TLTFF trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas TLTFF's P/E ratio is -16.29. In terms of profitability, RYLPF's ROE is +0.01%, compared to TLTFF's ROE of -2.57%. Regarding short-term risk, RYLPF is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check TLTFF's competition here
RYLPF vs NVYTF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, NVYTF has a market cap of 35.4M. Regarding current trading prices, RYLPF is priced at $27.08, while NVYTF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas NVYTF's P/E ratio is -0.68. In terms of profitability, RYLPF's ROE is +0.01%, compared to NVYTF's ROE of +0.00%. Regarding short-term risk, RYLPF is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check NVYTF's competition here
RYLPF vs ELXMF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, ELXMF has a market cap of 28.5M. Regarding current trading prices, RYLPF is priced at $27.08, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, RYLPF's ROE is +0.01%, compared to ELXMF's ROE of -0.39%. Regarding short-term risk, RYLPF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check ELXMF's competition here
RYLPF vs MKEAF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, RYLPF is priced at $27.08, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, RYLPF's ROE is +0.01%, compared to MKEAF's ROE of +0.47%. Regarding short-term risk, RYLPF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check MKEAF's competition here
RYLPF vs KBBTF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, RYLPF is priced at $27.08, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, RYLPF's ROE is +0.01%, compared to KBBTF's ROE of N/A. Regarding short-term risk, RYLPF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check KBBTF's competition here
RYLPF vs EMITF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, EMITF has a market cap of 23.9M. Regarding current trading prices, RYLPF is priced at $27.08, while EMITF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas EMITF's P/E ratio is -12.00. In terms of profitability, RYLPF's ROE is +0.01%, compared to EMITF's ROE of -0.08%. Regarding short-term risk, RYLPF is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check EMITF's competition here
RYLPF vs POSC Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, POSC has a market cap of 22.7M. Regarding current trading prices, RYLPF is priced at $27.08, while POSC trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas POSC's P/E ratio is 0.32. In terms of profitability, RYLPF's ROE is +0.01%, compared to POSC's ROE of +9.25%. Regarding short-term risk, RYLPF is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check POSC's competition here
RYLPF vs GTHP Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, GTHP has a market cap of 20.6M. Regarding current trading prices, RYLPF is priced at $27.08, while GTHP trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas GTHP's P/E ratio is -5.23. In terms of profitability, RYLPF's ROE is +0.01%, compared to GTHP's ROE of +0.71%. Regarding short-term risk, RYLPF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check GTHP's competition here
RYLPF vs PYNKF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, PYNKF has a market cap of 19.2M. Regarding current trading prices, RYLPF is priced at $27.08, while PYNKF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas PYNKF's P/E ratio is -0.80. In terms of profitability, RYLPF's ROE is +0.01%, compared to PYNKF's ROE of -1.58%. Regarding short-term risk, RYLPF is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check PYNKF's competition here
RYLPF vs DIZTF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, RYLPF is priced at $27.08, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, RYLPF's ROE is +0.01%, compared to DIZTF's ROE of -2.22%. Regarding short-term risk, RYLPF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check DIZTF's competition here
RYLPF vs ASAPF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, ASAPF has a market cap of 15M. Regarding current trading prices, RYLPF is priced at $27.08, while ASAPF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas ASAPF's P/E ratio is -19.25. In terms of profitability, RYLPF's ROE is +0.01%, compared to ASAPF's ROE of -0.23%. Regarding short-term risk, RYLPF is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check ASAPF's competition here
RYLPF vs MDXHF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, MDXHF has a market cap of 14.2M. Regarding current trading prices, RYLPF is priced at $27.08, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, RYLPF's ROE is +0.01%, compared to MDXHF's ROE of +0.49%. Regarding short-term risk, RYLPF is less volatile compared to MDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check MDXHF's competition here
RYLPF vs TMDIF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, RYLPF is priced at $27.08, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, RYLPF's ROE is +0.01%, compared to TMDIF's ROE of -0.57%. Regarding short-term risk, RYLPF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check TMDIF's competition here
RYLPF vs VPTDF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, VPTDF has a market cap of 13.6M. Regarding current trading prices, RYLPF is priced at $27.08, while VPTDF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas VPTDF's P/E ratio is -4.07. In terms of profitability, RYLPF's ROE is +0.01%, compared to VPTDF's ROE of +1.70%. Regarding short-term risk, RYLPF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check VPTDF's competition here
RYLPF vs PLLWF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, PLLWF has a market cap of 13.3M. Regarding current trading prices, RYLPF is priced at $27.08, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, RYLPF's ROE is +0.01%, compared to PLLWF's ROE of -0.61%. Regarding short-term risk, RYLPF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check PLLWF's competition here
RYLPF vs IMEXF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, IMEXF has a market cap of 11.8M. Regarding current trading prices, RYLPF is priced at $27.08, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas IMEXF's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.01%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, RYLPF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check IMEXF's competition here
RYLPF vs ATBPF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, RYLPF is priced at $27.08, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, RYLPF's ROE is +0.01%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, RYLPF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check ATBPF's competition here
RYLPF vs LXXGF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, RYLPF is priced at $27.08, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, RYLPF's ROE is +0.01%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, RYLPF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check LXXGF's competition here
RYLPF vs NGMDF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, NGMDF has a market cap of 9.3M. Regarding current trading prices, RYLPF is priced at $27.08, while NGMDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas NGMDF's P/E ratio is -4.08. In terms of profitability, RYLPF's ROE is +0.01%, compared to NGMDF's ROE of +0.36%. Regarding short-term risk, RYLPF is more volatile compared to NGMDF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check NGMDF's competition here
RYLPF vs FZMD Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, FZMD has a market cap of 6.4M. Regarding current trading prices, RYLPF is priced at $27.08, while FZMD trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas FZMD's P/E ratio is 1.44. In terms of profitability, RYLPF's ROE is +0.01%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, RYLPF is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check FZMD's competition here
RYLPF vs RMSL Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, RMSL has a market cap of 6.1M. Regarding current trading prices, RYLPF is priced at $27.08, while RMSL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas RMSL's P/E ratio is 0.40. In terms of profitability, RYLPF's ROE is +0.01%, compared to RMSL's ROE of -2.86%. Regarding short-term risk, RYLPF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check RMSL's competition here
RYLPF vs QLIS Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, RYLPF is priced at $27.08, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas QLIS's P/E ratio is 2.22. In terms of profitability, RYLPF's ROE is +0.01%, compared to QLIS's ROE of -0.95%. Regarding short-term risk, RYLPF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check QLIS's competition here
RYLPF vs RHNMF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, RYLPF is priced at $27.08, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, RYLPF's ROE is +0.01%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, RYLPF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check RHNMF's competition here
RYLPF vs ODYY Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, ODYY has a market cap of 4.6M. Regarding current trading prices, RYLPF is priced at $27.08, while ODYY trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas ODYY's P/E ratio is -0.32. In terms of profitability, RYLPF's ROE is +0.01%, compared to ODYY's ROE of +2.30%. Regarding short-term risk, RYLPF is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check ODYY's competition here
RYLPF vs ALRTF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, ALRTF has a market cap of 4.5M. Regarding current trading prices, RYLPF is priced at $27.08, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas ALRTF's P/E ratio is -0.24. In terms of profitability, RYLPF's ROE is +0.01%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, RYLPF is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check ALRTF's competition here
RYLPF vs VYCO Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, VYCO has a market cap of 4.3M. Regarding current trading prices, RYLPF is priced at $27.08, while VYCO trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas VYCO's P/E ratio is -13.00. In terms of profitability, RYLPF's ROE is +0.01%, compared to VYCO's ROE of +0.02%. Regarding short-term risk, RYLPF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check VYCO's competition here
RYLPF vs LBLTF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, LBLTF has a market cap of 4.1M. Regarding current trading prices, RYLPF is priced at $27.08, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, RYLPF's ROE is +0.01%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, RYLPF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check LBLTF's competition here
RYLPF vs ADMT Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, ADMT has a market cap of 4.1M. Regarding current trading prices, RYLPF is priced at $27.08, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas ADMT's P/E ratio is -6.00. In terms of profitability, RYLPF's ROE is +0.01%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, RYLPF is less volatile compared to ADMT. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check ADMT's competition here
RYLPF vs PMEDF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, PMEDF has a market cap of 3.5M. Regarding current trading prices, RYLPF is priced at $27.08, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas PMEDF's P/E ratio is -1.81. In terms of profitability, RYLPF's ROE is +0.01%, compared to PMEDF's ROE of +0.80%. Regarding short-term risk, RYLPF is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check PMEDF's competition here
RYLPF vs VANIW Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, RYLPF is priced at $27.08, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas VANIW's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.01%, compared to VANIW's ROE of -1.95%. Regarding short-term risk, RYLPF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check VANIW's competition here
RYLPF vs BIEL Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, BIEL has a market cap of 2.7M. Regarding current trading prices, RYLPF is priced at $27.08, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas BIEL's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.01%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, RYLPF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check BIEL's competition here
RYLPF vs NUMD Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, NUMD has a market cap of 2.7M. Regarding current trading prices, RYLPF is priced at $27.08, while NUMD trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas NUMD's P/E ratio is 3.20. In terms of profitability, RYLPF's ROE is +0.01%, compared to NUMD's ROE of +0.27%. Regarding short-term risk, RYLPF is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check NUMD's competition here
RYLPF vs TBRIF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, TBRIF has a market cap of 2.6M. Regarding current trading prices, RYLPF is priced at $27.08, while TBRIF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas TBRIF's P/E ratio is -0.75. In terms of profitability, RYLPF's ROE is +0.01%, compared to TBRIF's ROE of -2.28%. Regarding short-term risk, RYLPF is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check TBRIF's competition here
RYLPF vs USAQ Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, USAQ has a market cap of 2.1M. Regarding current trading prices, RYLPF is priced at $27.08, while USAQ trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas USAQ's P/E ratio is -4.75. In terms of profitability, RYLPF's ROE is +0.01%, compared to USAQ's ROE of +0.68%. Regarding short-term risk, RYLPF is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check USAQ's competition here
RYLPF vs ESMC Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, ESMC has a market cap of 2M. Regarding current trading prices, RYLPF is priced at $27.08, while ESMC trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas ESMC's P/E ratio is 5.40. In terms of profitability, RYLPF's ROE is +0.01%, compared to ESMC's ROE of +0.31%. Regarding short-term risk, RYLPF is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check ESMC's competition here
RYLPF vs CRRVF Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, CRRVF has a market cap of 1.5M. Regarding current trading prices, RYLPF is priced at $27.08, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas CRRVF's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.01%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, RYLPF is less volatile compared to CRRVF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.Check CRRVF's competition here
RYLPF vs LLBO Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, LLBO has a market cap of 1.3M. Regarding current trading prices, RYLPF is priced at $27.08, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas LLBO's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is +0.01%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, RYLPF is more volatile compared to LLBO. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check LLBO's competition here
RYLPF vs CYDX Comparison August 2025
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 25.7B. In comparison, CYDX has a market cap of 1.3M. Regarding current trading prices, RYLPF is priced at $27.08, while CYDX trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 142.53, whereas CYDX's P/E ratio is 0.33. In terms of profitability, RYLPF's ROE is +0.01%, compared to CYDX's ROE of +0.17%. Regarding short-term risk, RYLPF is more volatile compared to CYDX. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.Check CYDX's competition here